Expected Annual Base Salary Range for role: 169,400.00 - 314,600.00 CHF
In this senior International CLS leadership role, you will help shape the global launch strategy for a transformative treatment in one of two blood disorders; chronic myelogenous leukemia (CML) or myelofibrosis (MF), driving impact across diverse markets and healthcare systems. You will combine scientific insight, commercial expertise, and cross-functional partnership to support timely market entry and sustainable growth. Working closely with international and country teams, you will guide strategic decision-making, integrate market and customer insights, and encourage innovative approaches that expand patient access and strengthen leadership in haematology. This is an opportunity to influence the journey from development to commercialisation while enabling teams across regions to make a meaningful difference for people living with serious blood cancers.
Welcome to where we thrive together! Our aspiration at Novartis is to grow by ensuring every patient has access to the medicine they need as soon as possible.